Although structural MRI can detect PSP signs at more advanced stages, emerging diagnostic tools such as tau-PET and quantitative susceptibility mapping (QSM) may allow for earlier detection. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.